SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. announced today that new clinical and scientific evidence has emerged supporting the effectiveness of V.A.C. VeraFlo™ Instillation Therapy (NPWTi) compared to traditional V.A.C.® Therapy (NPWT). The studies showed reductions in the key metrics of hospital length of stay, time to wound closure and debridement costs with V.A.C. VeraFlo™ Therapy compared to traditional NPWT. The findings were recently featured during three independent presentations at the Diabetic Limb Salvage Conference in Washington, D.C. as part of an unrestricted educational grant, and two presentations at a KCI-sponsored Clinical Symposium on Advances in Skin & Wound Care Conference in Lake Buena Vista, Florida.
Help employers find you! Check out all the jobs and post your resume.
